• Vaccine Name: L612 HuMAb
• Target Pathogen: Cancer
• Target Disease: Cancer
• Vaccine Ontology ID: VO_0007631
• Type: human IgM monoclonal antibody
• Status: Licensed
• Antigen: GM3
• Immunization Route: Intramuscular injection (i.m.)
• Description: The human IgM monoclonal antibody, L612 HuMAb, was well tolerated. Infusion of L612 HuMAb appears to produce significant antitumor activity in melanoma patients (Irie et al., 2004).

Human Response

• Vaccine Immune Response Type: VO_0003057
• Immune Response: Serum antibody levels peaked 24 to 48 h after starting the infusion (Irie et al., 2004).